Yokohama, Japan

Kenichi Fushihara


Average Co-Inventor Count = 10.4

ph-index = 4

Forward Citations = 36(Granted Patents)


Location History:

  • Kanagawa-ken, JP (1997 - 1998)
  • Ayase, JP (2003 - 2004)
  • Yokohama, JP (2001 - 2007)

Company Filing History:


Years Active: 1997-2007

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Kenichi Fushihara: Innovator in Antiallergic Agents

Introduction

Kenichi Fushihara is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiallergic agents. With a total of 8 patents to his name, Fushihara's work has had a considerable impact on medical science.

Latest Patents

Fushihara's latest patents include innovative compounds known as tricyclic triazolobenzazepine derivatives. These compounds are designed to serve as antiallergic agents and exhibit excellent bioavailability. The patents detail a process for producing these compounds, which involves several chemical reactions to create pharmacologically acceptable salts and solvates. The compounds are represented by specific formulas, showcasing their potential utility in treating allergic conditions.

Career Highlights

Throughout his career, Kenichi Fushihara has worked with prominent companies in the pharmaceutical industry, including Meiji Seika Kaisha, Ltd. and Meiji Seika Kabushiki Kaisha. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Fushihara has collaborated with esteemed colleagues such as Yasuo Ohtsuka and Takashi Shishikura. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Kenichi Fushihara's contributions to the field of pharmaceuticals, particularly in the area of antiallergic agents, highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the industry and offers promising solutions for allergy sufferers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…